Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARTERIAL VASCULAR ENGINEERING -- Ignore unavailable to you. Want to Upgrade?

To: Zeus549 who wrote (303)	11/16/1997 2:54:00 PM
From: Stuolson	Respond to of 339

According to Comtex, two filings by director Simon Stertzer, one for sale of 120,000 and one for sale of 20,000 shares.

To: Zeus549 who wrote (303)	11/16/1997 3:47:00 PM
From: Stuolson	Respond to of 339

You may want to take a look at the most recent filings on Insider Trader( www.insidertrader.com)- showing that at the end of October insiders sold 175,000 shares of AVEI and filed additional 144s to sell 342,000 more shares. Seems like very heavy selling to me for a stock where there are " no problems".

To: Zeus549 who wrote (303)	11/20/1997 5:49:00 PM
From: Jeff Gurian	Read Replies (1) \| Respond to of 339

Hi Lee. Anything new? Nothing here. I talked with my friend who works at AVE and he had not heard anything about any rumors. From what I gathered, most people at AVE are now just "ho-hum" about the stock and no one expecets anything major to happen until FDA approval. He does know of some higher level people who have been selling but even they are just taking a profit (allot of them are selling some of their shares from their ipo still, others who bought while in the teens.) I sold my AVE "play" money at a slight loss the other day and put it into some long term 3Com. Its beginning to look like its not going to make 60 again anytime soon. No reason to play with anything that does not appear to be going anywhere special.